Diminished (Na,K)-ATPase activity in diabetic peripheral nerve is attributed to an underlying depletion of free myo-inositol, but no biochemical mechanism linking myo-inositol metabolism and (Na,K)-ATPase has emerged. Since inositol phospholipid turnover releases inositol-(1,4,5)-tris-phosphate and diacylglycerol, two putative "second messengers" that modulate protein kinase C, the effect of protein kinase C agonists on (Na,K)-ATPase activity was examined in diabetic nerve. Phorbol myristate acetate or the diacylglycerol sn-1,2-dioctanoylglycerol acutely normalized depressed ouabain-inhibitable respiration [a measure of (Na,K)-ATPase activity], suggesting that myo-inositol metabolism modulates (Na,K)-ATPase activity via protein kinase C, and that reduced myo-inositol impairs (Na,K)-ATPase activity in diabetic nerve by this mechanism. DIABETES 1986; 35:242-45.
abolic defect initiated by elevated ambient glucose concentrations in tissues susceptible to diabetic complications ( Figure 1 ). Because Ml is primarily incorporated into phospholipid, defects in phosphoinositide metabolism 1116 have been invoked in this postulated cycle in diabetic peripheral nerve (Figure 1 ).
Membrane phosphoinositide turnover releases inositol-(1,4,5)-tris-phosphate (IP 3 ) and diacylglycerol (DG), 17 two metabolites that respectively mobilize intracellular Ca 2+ (although Ca 2+ -independent protein kinase activation has recently been proposed for IP 3 18 and activate protein kinase C (by lowering its Ca 2+ requirement to within the physiologic intracellular concentration range. 19 Hence, these two "second messengers" may act independently or synergistically in translating exogenously stimulated phosphoinositide turnover into intracellular messages for metabolic regulation. 1719 (Na.K)-ATPase activity in erythroleukemic cells is regulated by cyclic-AMP-independent membrane-bound protein kinase activity; 20 similar regulation in peripheral nerve by phosphoinositide-mediated protein kinase C activation could explain the Ml-related (Na.K)-ATPase defect in diabetic nerve. If diminished (Na.K)-ATPase activity in diabetic nerve reflects a reduction in protein kinase C activity, then agonists that stimulate protein kinase C, such as DG and phorbol esters, should accordingly normalize (Na.K)-ATPase in diabetic peripheral nerve. 21 The present studies explore the ability of two protein kinase C agonists, phorbol myristate acetate (PMA) and sn-1,2-dioctanoylglycerol (diC 8 ), 22 to acutely normalize the reduced ouabain-inhibitable oxygen consumption in diabetic endoneurial preparations that reflects the reduced (Na.K)-ATPase activity.
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MATERIALS AND METHODS
Diabetes (fasting plasma glucose >300 mg/dl) was induced in 1.5-2.0-kg male New Zealand white rabbits by i.v. alloxan monohydrate (90 mg/kg). 24 Two weeks later, alloxan-injected and untreated control rabbits were fasted overnight (mean ± SEM fasting plasma glucose in diabetics of 477 ± 16 mg/dl, N = 42) and anesthetized, after which Hyperglycemia souri, and were of the highest available purity unless otherwise specified. paired endoneurial preparations were derived from their left and right sciatic nerve using controlled collagenase (Type I) digestion and microdissection, as previously described in detail. 32324 Endoneurial preparations were equilibrated for 10 min and incubated for 1 h in 3 ml of 4.5% dialyzed defatted bovine serum albumin (fraction V powder) and 5 mM glucose in Krebs-Ringer bicarbonate buffer (pH 7.4) equilibrated with 5% CO 2 /95% O 2 in 10-ml Erlenmeyer flasks in a Dubnoff metabolic shaker at 88 cycles/min and 37°C. Stocks of PMA, 4-alpha phorbol (4a-P) (both 300 jig/ml), and diC 8 (50 mM) were prepared in dimethylsulfoxide (DMSO), and 10 jxL was added to 3 ml of incubation medium for final phorbol concentrations of 2 |xM for PMA and 167 |xM for diC 8 during the 1-h incubation period; 10 |il of DMSO was added to control flasks for a DMSO concentration of 0.33% in all incubation flasks. Ouabain (2 mM) or amiloride (Merck Sharp and Dohme, West Point, Pennsylvania) (0.2-1 mM) was added in selected experiments for the last 10 or 30 min, respectively, and was present during the measurement of oxygen consumption. Linear oxygen consumption was recorded for at least 15 min in a Model 53 biological oxygen monitor (Yellow Springs Instruments Co., Yellow Springs, Ohio) containing 3 ml of fresh medium. In selected experiments, incubated endoneurial preparations were snap frozen and homogenized for enzymatic determination of ouabain-inhibitable respiration, as previously described in detail for rat nerve 8 only here using a higher saturating concentration of ouabain (2 mM). Data are shown as mean ± SEM. Differences between groups were analyzed by Student's two-tailed Mest, and between pairs by the f-test for paired comparisons. All reagents were purchased from Sigma Chemical Co., St. Louis, Mis-
RESULTS
PMA had no acute effect on resting oxygen consumption in endoneurial preparations from nondiabetic animals ( Figure  2 , column 1). Resting oxygen consumption was reduced by approximately 40% in endoneurial preparations derived from 2-wk-old alloxan-diabetic animals, but PMA acutely corrected this abnormality in vitro (Figure 2, column 2) . Ouabain completely eradicated the effect of PMA (Figure 2, column 3) , indicating that PMA acted on the ouabain-inhibitable component of respiration, which mirrors (Na.K)-ATPase activity. 2425 In human leukemic cells, phorbol esters stimulate (Na.K)-ATPase activity indirectly by enhancing (Na + ,H + )exc'hange, an effect originally thought to be blocked by 0.2 mM amiloride, 26 but later shown to require fivefold higher concentrations of amiloride that also appeared to directly inhibit protein kinase C. 27 In order to determine if the action of protein kinase C agonists on (Na.K)-ATPase in diabetic nerve was similarly mediated by (Na + ,H + )exchange, PMA was tested on paired diabetic endoneurial samples exposed to 0.2 or 1 mM amiloride for 30 min [recognizing that an effect at the higher concentration could reflect either mediation by the (Na + ,H + )exchanger or direct inhibition of protein kinase C]. At both concentrations, the full stimulatory effect of PMA on respiration was preserved ( eluding a significant role for amiloride-sensitive (Na + ,H + )exchange in this phenomenon. To establish that the effect of PMA on ouabain-inhibitable respiration was mediated by an alteration in (Na.K)-ATPase activity, ouabain-inhibitable ATPase activity was measured in crude homogenates of paired diabetic endoneurial preparations exposed to PMA or DMSO alone. PMA significantly increased ouabain-inhibitable ATPase activity by approximately 90% from 14.7 ±2.2 to 27.8 ± 2.4 |Amol/g/h (mean difference of paired samples, 13.1 ±2.5 ixmol/g/h, N = 7, P < 0.005). To examine the specificity of the action of PMA on diabetic nerve (Na,K)-ATPase, a protein-kinase C-inactive phorbol analogue (4a-P) and a nonphorbol protein-kinase-stimulating DG were tested. 4a-P had no effect on diabetic endoneurial respiration (Figure 2, column 6 ), but diC 8 , a short-chain symmetrical DG known to stimulate protein kinase C in human platelets, 22 reproduced the effect of PMA (Figure 2, column 7) . Thus, the reduction in ouabain-inhibitable respiration in endoneurial preparations from diabetic animals was acutely, specifically, and completely corrected by agonists that stimulate protein kinase C activity. This effect was not mediated by amiloridesensitive (Na + ,H + )exchange, or changes in water-soluble cofactors or substrates for the (Na,K)-ATPase, since the effect persisted in broken cell preparations.
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DISCUSSION
Decreased steady-state respiration in endoneurial preparations from diabetic rabbits is attributed to a reduction in (Na.K)-ATPase activity; endoneurial Ml is also depressed by alloxan diabetes in the rabbit. 24 An analogous (Na.K)-ATPase defect in the streptozocin-diabetic rat measured enzymatically in crude nerve homogenates is preventable by either dietary Ml supplementation 8 or aldose reductase inhibitors 28 that normalize the decreased nerve Ml content. In view of the action of PMA and diC 8 on ouabain-inhibitable respiration in diabetic endoneurial preparations, and the rapidly emerging relationship between inositol phospholipid metabolism and protein kinase C modulation, 1719 it is reasonable to infer that this reduction in (Na.K)-ATPase activity in diabetic nerve most likely mirrors decreased protein kinase C activity. These data are compatible with a direct phosphorylation of (Na,K)-ATPase or an associated regulatory membrane protein by protein kinase C. [A less likely possibility is that lipophilic agents that activate protein kinase C interact with a homologous lipid domain of the (Na,K)-ATPase, thereby directly modulating its activity as well.] In any case, the expression of the (Na.K)-ATPase defect in the broken cell preparations of diabetic rat nerve localizes the biochemical lesion entirely within the (Na,K)-ATPase-membrane complex.
Poorly understood consequences of hyperglycemia on nerve, retina, renal glomerulus, and arterial wall metabolism are thought to heavily influence the development of diabetic complications. These tissues share in common a reduction in cellular free Ml and (Na.K)-ATPase in response to elevated ambient glucose concentration; 1 -7 by extension of the present observations in nerve, a common defect in protein kinase C activity may be inferred in these other tissues. Although its endogenous substrates have not yet been fully defined, protein kinase C phosphorylates a broad range of proteins. 19 In nerve, this Ml-related protein kinase C defect appears to explain the rapidly reversible slowing of conduction velocity in diabetic rats via its effect on (Na.K)-ATPase activity. 29 A reduction of protein kinase C activity in nerve, retina, renal glomerulus, and arterial wall might also explain other complex and poorly understood responses of these tissues to the diabetic state. Thus, protein kinase C may become a major focus of research into the complications of diabetes, and diabetes might now serve as a model in which to explore the physiologic role of protein kinase C and its possible modulation of (Na.K)-ATPase.
